Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William P Tew

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 31, 2024
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case seriesTiffany Y Sia, Vivian Wan, Michael Finlan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2021
Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast CancerAllison Magnuson, Mina S Sedrak, Cary P Gross, et al.
Gynecologic Oncology|September 22, 2016
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice GuidelineAlexi A Wright, Kari Bohlke, Deborah K Armstrong, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case seriesTiffany Y Sia, Vivian Wan, Michael Finlan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2016
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice GuidelineAlexi A Wright, Kari Bohlke, Deborah K Armstrong, et al.
Gynecologic Oncology|March 16, 2022
Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissuesLea A Moukarzel, Lorenzo Ferrando, Higinio Dopeso, et al.
Cancer|November 14, 2023
Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trialJingran Ji, Marie Bae, Can-Lan Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2025
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline UpdateStéphanie Gaillard, Christina Lacchetti, Deborah K Armstrong, et al.
Gynecologic Oncology|September 12, 2024
Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14Jubilee Brown, Austin Miller, Laura L Holman, et al.
CA: a Cancer Journal for Clinicians|October 1, 2020
Older adult participation in cancer clinical trials: A systematic review of barriers and interventionsMina S Sedrak, Rachel A Freedman, Harvey J Cohen, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 31, 2024
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case seriesTiffany Y Sia, Vivian Wan, Michael Finlan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2021
Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast CancerAllison Magnuson, Mina S Sedrak, Cary P Gross, et al.
Gynecologic Oncology|September 22, 2016
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice GuidelineAlexi A Wright, Kari Bohlke, Deborah K Armstrong, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case seriesTiffany Y Sia, Vivian Wan, Michael Finlan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2016
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice GuidelineAlexi A Wright, Kari Bohlke, Deborah K Armstrong, et al.
Gynecologic Oncology|March 16, 2022
Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissuesLea A Moukarzel, Lorenzo Ferrando, Higinio Dopeso, et al.
Cancer|November 14, 2023
Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trialJingran Ji, Marie Bae, Can-Lan Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2025
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline UpdateStéphanie Gaillard, Christina Lacchetti, Deborah K Armstrong, et al.
Gynecologic Oncology|September 12, 2024
Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14Jubilee Brown, Austin Miller, Laura L Holman, et al.
CA: a Cancer Journal for Clinicians|October 1, 2020
Older adult participation in cancer clinical trials: A systematic review of barriers and interventionsMina S Sedrak, Rachel A Freedman, Harvey J Cohen, et al.
Pageof 12